Original Research
Published on 15 Sep 2022
Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-ÎşB and beta-catenin pathways
in Cancer Molecular Targets and Therapeutics
- 2,973 views
- 6 citations
Original Research
Published on 15 Sep 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 14 Sep 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 14 Sep 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 14 Sep 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 14 Sep 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 12 Sep 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 12 Sep 2022
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 08 Sep 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 08 Sep 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 07 Sep 2022
in Cancer Molecular Targets and Therapeutics
Brief Research Report
Published on 06 Sep 2022
in Cancer Molecular Targets and Therapeutics
Mini Review
Published on 02 Sep 2022
in Cancer Molecular Targets and Therapeutics
Mini Review
Published on 02 Sep 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 02 Sep 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 31 Aug 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 31 Aug 2022
in Cancer Molecular Targets and Therapeutics